Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1
Proceedings of the National Academy of Sciences · 14.01.2025 · 122 (2)
DOI: 10.1073/pnas.2418985122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 09.01.2025. Verfasst von Stephen Mok und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Hauptthemen laut MEDLINE: Immunologic Memory, CTLA-4 Antigen, Programmed Cell Death 1 Receptor, Mice, Knockout. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH (NIH), Cancer Prevention and Research Institute of Texas (CPRIT), NIAID NIH HHS.
Abstract (Originalsprache)
The effects of T cell differentiation arising from immune checkpoint inhibition targeting cytotoxic T lymphocyte–associated antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1) on the immunological memory response remain unclear. Our investigation into the effects of anti-CTLA-4 and anti-PD-1 on memory T cell formation in mice reveals that memory T cells generated by anti-CTLA-4 exhibit greater expansion, cytokine production, and antitumor activity than those from anti-PD-1. Notably, anti-CTLA-4 preserves more T cell factor-1 (TCF-1)+ T cells during priming, while anti-PD-1 leads to more thymocyte selection-associated high mobility group box (TOX)+ T cells. Experiments using conditional Tcf7 - or Tox -knockout mice highlight that TCF-1 is essential for the memory response generated by anti-CTLA-4, whereas TOX deletion alone in T cells has no effect on the response to anti-PD-1. Deepening our understanding of how checkpoint inhibition affects memory response is crucial for advancing our understanding of the enduring impacts of these immunotherapies on the immune system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
- James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
- Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104.
- Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
ORCID-Profile: Nana-Ama A S Anang, James J Mancuso, E John Wherry
Förderung
- HHS | NIH (NIH)
- Cancer Prevention and Research Institute of Texas (CPRIT)
- NIAID NIH HHS
Zitieren
APA
Mok, S., Liu, H., Ağaç Çobanoğlu, D., Anang, N. A. S., Mancuso, J. J., Wherry, E. J., & Allison, J. P. (2025). Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1. Proceedings of the National Academy of Sciences, 122(2). https://doi.org/10.1073/pnas.2418985122
Vancouver
Mok S, Liu H, Ağaç Çobanoğlu D, Anang NAS, Mancuso JJ, Wherry EJ, et al. Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1. Proceedings of the National Academy of Sciences. 2025;122(2). doi:10.1073/pnas.2418985122
BibTeX
@article{Mok2025,
author = {Mok, Stephen and Liu, Huey and Ağaç Çobanoğlu, Didem and Anang, Nana-Ama A S and Mancuso, James J and Wherry, E John and Allison, James P},
title = {Anti-CTLA-4 generates greater memory response than anti-PD-1 via TCF-1},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {2},
doi = {10.1073/pnas.2418985122}
}
EUVIMED